EP
Eversept Partners’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3M | Sell |
277,316
-269,800
| -49% | -$14.9M | 1.41% | 25 |
|
|
2025
Q1 | $26.5M | Sell |
547,116
-131,671
| -19% | -$6.37M | 2.69% | 9 |
|
|
2024
Q4 | $26.2M | Buy |
678,787
+233,583
| +52% | +$9.02M | 2.33% | 10 |
|
|
2024
Q3 | $20M | Sell |
445,204
-60,632
| -12% | -$2.73M | 1.37% | 17 |
|
|
2024
Q2 | $17.5M | Buy |
505,836
+94,358
| +23% | +$3.27M | 1.2% | 19 |
|
|
2024
Q1 | $11.9M | Sell |
411,478
-126,596
| -24% | -$3.66M | 0.79% | 22 |
|
|
2023
Q4 | $12.3M | Buy |
538,074
+251,326
| +88% | +$5.76M | 1.08% | 20 |
|
|
2023
Q3 | $4.78M | Buy |
286,748
+172,089
| +150% | +$2.87M | 0.4% | 36 |
|
|
2023
Q2 | $3.17M | Buy |
+114,659
| New | +$3.17M | 0.26% | 47 |
|